Health
GSK cancer drug approved by US regulators
Key Points
Lung cancer treatment was at the heart of FTSE 100 group’s $10.6bn acquisition of Nuvalent
Lung cancer treatment was at the heart of FTSE 100 group’s $10.6bn acquisition of Nuvalent